Preview

Regulatory Research and Medicine Evaluation

Advanced search

Technology Mapping as a New Mechanism for Managing Medicinal Product Development

https://doi.org/10.30895/1991-2919-2026-16-3-246-251

Abstract

In this interview, D.I. Fedorova, First Deputy Director of the Medical Technology Transfer Centre at the Scientific Centre for Expert Evaluation of Medicinal Products, describes practical, data-driven tools that support the management of scientific and technological development in the pharmaceutical sector. The central topic is technology mapping, an approach that enables a systems-level analysis of research directions, technology maturity levels, and implementation potential. The interview outlines how this tool can be used by government authorities and other decision-makers to adjust research priorities, allocate resources, and mitigate risks, and what value it provides to pharmaceutical and biotechnology companies when building development portfolios.

About the Author

D. I. Fedorova
Scientific Centre for Expert Evaluation of Medicinal Products
Russian Federation

Darya I. Fedorova 

8/2 Petrovsky Blvd., Moscow 127051 



Review

For citations:


Fedorova D.I. Technology Mapping as a New Mechanism for Managing Medicinal Product Development. Regulatory Research and Medicine Evaluation. 2026;16(3):246-251. (In Russ.) https://doi.org/10.30895/1991-2919-2026-16-3-246-251

Views: 97

JATS XML


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 3034-3062 (Print)
ISSN 3034-3453 (Online)